There is no better way to get a glimpse into the future of the region’s life sciences ecosystem than the 8th annual BioHealth Capital Region (BHCR) Forum, which is fast approaching. The 2022 BHCR Forum is a can’t miss in-person/live streamed event hosted at United States Pharmacopeia (USP) in Rockville, Maryland on September 20th. Also, on September 21st at USP will be the 5th Annual BioHealth Capital Region Investment Conference and the 7th Annual Crab Trap Competition.
Prestigious Annual Pediatric Medical Device Pitch Competition Returns with $150K in FDA Awards and Accelerator Program
Recognizing the continued gap in the development and commercialization of medical devices for children versus adults, the National Capital Consortium for Pediatric Device Innovation (NCC-PDI), in collaboration with MedTech Innovator, is accepting applications through April 22, 2022, for its annual “Make Your Medical Device Pitch for Kids!” competition. Recognizing the wide range of unmet needs for diagnostic and therapeutic devices designed especially for children, this year’s competition is open to any innovation in medical technology that addresses a significant unmet need in pediatric medical care.
Our CEO of the Year stood at the nexus of all of those issues, on the literal front lines of the health crisis amid a financial downturn and worker shortage. He was working to not only sustain, but also grow, his organization, even as he assumed responsibility for attending to our community’s most vulnerable population: our children.
He is Dr. Kurt Newman, president and CEO of Children’s National Hospital.
Children’s National Hospital joins the Mendelian Genomics Research Consortium, receiving $12.8 million
Children’s National Hospital announces a $12.8 million award from the National Institutes of Health’s National Human Genome Research Institute (NHGRI) to establish the only Pediatric Mendelian Genomics Research Center (PMGRC) as part of a new Mendelian Genomics Research Consortium. Researchers at Children’s National and Invitae — a leading medical genetics company — will identify novel causes of rare inherited diseases, investigate the mechanisms of undiagnosed conditions, enhance data sharing, and generally interrogate Mendelian phenotypes, which are conditions that run in families.
If you are interested in pediatric medical device innovation or alternative solutions to surgery such as focused ultrasound, these two topics will merge at the Pediatric Device Innovators Forum, July 22, from 2 – 3:30 p.m. This free livestream event, hosted by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI), features clinical, regulatory and reimbursement experts discussing the topic “Focused Ultrasound for Pediatric Indications.”
Children’s National Hospital announces licensing agreement with MGeneRx Inc. for proprietary biometric analysis technology
Children’s National Hospital announces that it has entered into a licensing agreement with MGeneRx Inc. for its patented pediatric medical device technology using objective digital biometric analysis software for the early and non-invasive screening of dysmorphic genetic diseases. The technology was developed by Children’s National to provide a more advanced diagnostic tool for regions of the world with limited access to geneticists or genetic testing. MGeneRx is a spinoff from BreakThrough BioAssets LLC, a life sciences technology operating company focused on accelerating and commercializing new innovations, such as this technology, with an emphasis on positive social impact.
Leading children’s hospital provides clinical validation, IP for health challenge designed to advance pediatric innovation
Five finalists have been named in the prestigious annual “Make Your Medical Device Pitch for Kids!” competition presented by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI). Representing innovations in electrophysiology devices that treat congenital heart disease (CHD) and arrhythmias in pediatric patients, these five finalists now have access to a pediatric accelerator program led by MedTech Innovator and will compete for a share of $150,000 in grant funding from the U.S. Food and Drug Administration (FDA) in the final virtual pitch event in September. The pediatric pitch event is part of the 9th Annual Symposium on Pediatric Device Innovation, co-located with the MedTech Conference, powered by AdvaMed.
Children’s National Research & Innovation Campus Welcomes New Resident Company, AlgometRx to JLABS @ Washington, DC Site
AlgometRx Inc., a Children’s National spinout company developing a handheld device to objectively measure pain by pupillary response, will relocate to Johnson & Johnson Innovation – JLABS @ Washington, DC on the Children’s National Research & Innovation Campus. The AlgometRx move comes following the company being awarded the JLABS @ Washington, DC Children’s QuickFire Challenge, which includes a one-year residency at the newly opened JLABS @ Washington, DC – a 32,000-square-foot incubator located at the new Children’s National Research & Innovation Campus in northwest Washington, D.C. As an awardee, AlgometRx also receives access to research and development space, capital equipment, mentorship, resources and programming.
Children’s National leaders provide expertise and support to advance SHIP-MD pediatric innovation initiative | Children’s National
The advancement of children’s medical devices in the U.S. continues to significantly lag behind adult devices for many reasons.